Cue biopharma to host investor call

Boston, june 07, 2023 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific t cells directly within the patient's body, announced today that it will host an investor call on wednesday, june 14, 2023.
CUE Ratings Summary
CUE Quant Ranking